Company
L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.
Recornea is a pre-clinical stage ophthalmic company developing new therapeutic corneal implants for the treatment of keratoconus. Our first product, the GROSSO Implant, is targeting keratoconus.
Udine, Friuli Venezia Giulia, Italy
Send a message
Anglais
Anglais
At RECORNEA, we secure your vision with advanced ophthalmic solutions. The first product we’ve developed is a ground-breaking solution, as a new corneal implant called the GROSSO® implant, to be implanted in a single and simple surgical procedure to treat a progressive eye disease called keratoconus. Both current ocular surgeries and competitor devices (i.e. intracorneal ring segments, ICRS) are not effective in reinstating a predictable, uniform and stable-in-time shape of...
At RECORNEA, we secure your vision with advanced ophthalmic solutions. The first product we’ve developed is a ground-breaking solution, as a new corneal implant called the GROSSO® implant, to be implanted in a single and simple surgical procedure to treat a progressive eye disease called keratoconus. Both current ocular surgeries and competitor devices (i.e. intracorneal ring segments, ICRS) are not effective in reinstating a predictable, uniform and stable-in-time shape of the cornea leading to a very poor quality of vision and life. Our product is the world's first metal corneal implant to restore the physiological curvature of the cornea with predictable clinical outcomes.
1
Followers
1
Like